AAB-001 in Patients With Mild to Moderate Alzheimer's Disease
Public ClinicalTrials.gov record NCT00112073. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIA, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, and Immunogenicity Trial of AAB-001 in Patients With Mild to Moderate AD
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the safety and tolerability of multiple doses of AAB-001 passive immunization in patients with mild to moderate Alzheimer's disease (AD).
Study identification
- NCT ID
- NCT00112073
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 234 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2005 (Type not available)
- Primary completion
- Nov 2008 (Actual)
- Completion
- Dec 2008 (Actual)
- Last update posted
- Mar 14, 2012
2005 – 2008
United States locations
- U.S. sites
- 26
- U.S. states
- 19
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cleo Roberts Center for Clinical Research / Sun Health Research Institute | Sun City | Arizona | 85351 | — |
| UC Irvine | Irvine | California | 92697 | — |
| Pharmacology Research Institute | Los Alamitos | California | 90720 | — |
| Pharmacology Research Institute | Northridge | California | 91324 | — |
| UCSD Shiley-Marcos Alzheimer's Disease Research Center | San Diego | California | — | — |
| Memory & Aging Center, UCSF | San Francisco | California | — | — |
| Yale University School of Medicine | New Haven | Connecticut | 06510 | — |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20057 | — |
| Brain Matters Research, Inc. | Delray Beach | Florida | 33445 | — |
| Mayo Clinic - Department of Neurology | Jacksonville | Florida | 32224 | — |
| Rush Presbyterian St. Luke's Medical Center | Chicago | Illinois | 60612 | — |
| Department of Neurology - Indiana University Medical Center | Indianapolis | Indiana | 46202 | — |
| Behavioral Neurology | Boston | Massachusetts | 02115 | — |
| University of Michigan Health System, Department of Neurology | Ann Arbor | Michigan | 48109 | — |
| Mayo Clinic Department of Neurology - Alzheimer's Disease Research Center | Rochester | Minnesota | 55905 | — |
| The Memory Enhancement Center | Long Branch | New Jersey | 07740 | — |
| Sergievsky Center, Columbia University | New York | New York | 10032 | — |
| University of Rochester / Monroe Community Hospital | Rochester | New York | 14620 | — |
| Department of Psychiatry and Behavioral Sciences | Durham | North Carolina | 27710 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | — |
| Memory and Aging Program, Butler Hospital | Providence | Rhode Island | 02906 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Clinical Neuroscience Research Associates, Inc. | Bennington | Vermont | 05201 | — |
| University of Washington | Seattle | Washington | 98108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00112073, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 14, 2012 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00112073 live on ClinicalTrials.gov.